Given the fundamental role of FoxO3 in cardiovascular and metabolic homeostasis, the function and fine-tuned regulation of its subcellular distribution is critical for the future development of specific and effective cardioprotective therapeutics in clinical situations combining obesity and myocardial damage. The gene discussed is FOXO3; the disease is obesity due to melanocortin 4 receptor deficiency.